See what questions
a doctor would ask.
Nemaline myopathy 2 is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Nemaline myopathy 2, or a subtype of Nemaline myopathy 2, affects less than 200,000 people in the US population.
The term 'prevalence' of Nemaline myopathy 2 usually refers to the estimated population of people who are managing Nemaline myopathy 2 at any given time. The term 'incidence' of Nemaline myopathy 2 refers to the annual diagnosis rate, or the number of new cases of Nemaline myopathy 2 diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.
Search Specialists by State and City